Study

EORTC-1335-LCG-PBG

SPECTAlung: Screening Patients with thoracic tumors for Efficient Clinical Trial Access

Study documentation Back to result

LT-FU ongoing

Date of activation: 22-May-2015
Date Step1 close: 18-Jun-2019
Date Step2 close: 18-Jun-2019

Yes

Cohort
Not randomized / N.A.

Benjamin Besse (Study Coordinator), Gustave Roussy, VILLEJUIF CEDEX
Thierry Gorlia (Statistician), EORTC Headquarters, Brussels
Lieve Dirix (Senior Clinical Operations Manager), EORTC Headquarters, Brussels
Maarten Spruyt (Data Manager), EORTC Headquarters, Brussels
Hadi Almidani (Pharmacovigilance Manager), EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager), EORTC Headquarters, Brussels

CHU de Lyon - Hopital Louis Pradel (BRON, France)
CHU de Toulouse - Hopital Larrey (TOULOUSE CEDEX 9, France)
Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
Gustave Roussy (VILLEJUIF CEDEX, France)
Hopital Nord (APHM) (Marseille, France)
Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain)
Hospital Universitario 12 De Octubre (Madrid, Spain)
Institut Jules Bordet (Anderlecht, Belgium)
Kingston Hospital NHS trust (Kingston upon Thames, United Kingdom)
Medical University Of Gdansk (Gdansk, Poland)
Royal Marsden Hospital - Chelsea, London (London, United Kingdom)
Royal Marsden Hospital - Sutton, Surrey (Surrey, United Kingdom)
St. James'S Hospital (Dublin, Ireland)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universita Di Torino - Ospedale S. Luigi Gonzaga (Orbassano-Torino, Italy)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
University Clinic Golnik (Golnik, Slovenia)

Alma Mater Studiorium Universita di Bologna - Loc. Ospedala Sant'Orsolo (Bologna, Italy)
Hospital Grosshansdorf (Grosshansdorf, Germany)
UniversitaetsSpital Zurich (Zurich, Switzerland)

NCT02214134